Seungtaek Kim to Humans
This is a "connection" page, showing publications Seungtaek Kim has written about Humans.
Connection Strength
0.038
-
TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351). Microbiol Spectr. 2021 09 03; 9(1):e0047221.
Score: 0.008
-
Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells. J Med Virol. 2021 03; 93(3):1403-1408.
Score: 0.007
-
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs. Antimicrob Agents Chemother. 2020 06 23; 64(7).
Score: 0.007
-
Immune responses and reactogenicity after ChAdOx1 in individuals with past SARS-CoV-2 infection and those without. J Infect. 2022 01; 84(1):94-118.
Score: 0.002
-
Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay. Proc Natl Acad Sci U S A. 2021 07 27; 118(30).
Score: 0.002
-
Platycodin D, a natural component of Platycodon grandiflorum, prevents both lysosome- and TMPRSS2-driven SARS-CoV-2 infection by hindering membrane fusion. Exp Mol Med. 2021 05; 53(5):956-972.
Score: 0.002
-
Comparison of Digital PCR and Quantitative PCR with Various SARS-CoV-2 Primer-Probe Sets. J Microbiol Biotechnol. 2021 03 28; 31(3):358-367.
Score: 0.002
-
Design, synthesis and biological evaluation of 2-aminoquinazolin-4(3H)-one derivatives as potential SARS-CoV-2 and MERS-CoV treatments. Bioorg Med Chem Lett. 2021 05 01; 39:127885.
Score: 0.002
-
Discovery of cyclic sulfonamide derivatives as potent inhibitors of SARS-CoV-2. Bioorg Med Chem Lett. 2021 01 01; 31:127667.
Score: 0.002
-
Natural Bis-Benzylisoquinoline Alkaloids-Tetrandrine, Fangchinoline, and Cepharanthine, Inhibit Human Coronavirus OC43 Infection of MRC-5 Human Lung Cells. Biomolecules. 2019 11 04; 9(11).
Score: 0.002
-
Generation of a Nebulizable CDR-Modified MERS-CoV Neutralizing Human Antibody. Int J Mol Sci. 2019 Oct 12; 20(20).
Score: 0.002
-
Effect of S267F variant of NTCP on the patients with chronic hepatitis B. Sci Rep. 2017 12 15; 7(1):17634.
Score: 0.001